About P&T JournalContacts:
Statement of Purpose
Guidelines for Authors
Health Care & Law
Pitfalls and Recommendations
Medication errors, with methotrexate in particular, are all too common — especially when patients are moved from one site of care to another. The authors discuss ways to improve appropriate medication use during patient transitions.
James O’Donnell, PharmD, MS; and F. Randy Vogenberg, RPh, PhD
Focus on Individualizing Non-Insulin Therapies
Successful management of hyperglycemia may involve glucose and non-glucose therapies, non-drug approaches, and non-insulin agents. Treatment should be tailored to each patient, with an emphasis on safety.
Luigi Brunetti, PharmD, MPH, BCPS, CGP; and Julie Kalabalik, PharmD, BCPS
Used together, sitagliptin (Januvia) and metformin (Glucophage) help to improve glycemic levels in diabetic patients, suggesting a synergy between the agents.
However, the cost of sitagliptin and the need for more data may restrict its use. More studies are needed to assess the effects of long-term sitagliptin and to determine its role in combination therapy.
Erin L. St. Onge, PharmD; Shannon Miller, PharmD; and Elizabeth Clements, PharmD
Topics include comparisons of bivalirudin (Angiomax) and unfractionated heparin in reducing bleeding, prasugrel (Effient) and clopidogrel (Plavix) in acute myocardial infarction, aspirin for critical limb ischemia, and mobilized CD34+ cells for angina.
Matthew Grissinger, RPh, FASCP
Republicans Say Requirements for Incentives Are Set Too Low
FDA approvals, drug indications, and updates
Marvin M. Goldenberg, PhD, RPh, MS